HBF-20478-52405
5 vaccinations
1 coded response
32 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 765 / TX
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2022-01-03
Dose 3 — Pfizer-BioNTech
-
2022-03-24
Survey response — 12 months, dose 2MedDRA: Haemophagocytic lymphohistiocytosis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: HLHMedDRA releases: 2024-11 · check-in free text available
-
2022-03-24
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-29
- 2022-04-01
-
2022-06-21
Dose 4 — Pfizer-BioNTech
-
2022-09-19
Dose 5 — Pfizer-BioNTech
- 2022-09-19
-
2022-09-21
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-09-23
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2022-01-03 | Pfizer-BioNTech | No |
| 4 | 2022-06-21 | Pfizer-BioNTech | No |
| 5 | 2022-09-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 12 months, dose 2
Symptoms: HLH
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Haemophagocytic lymphohistiocytosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release